North Carolina Clinical Research   Report issue

For profit Phase 2 Phase 3
Founded: Raleigh NC United States (1986)

Organization Overview

First Clinical Trial
2005
NCT00293657
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now